Linus Carl Pauling (February 28, 1901 – August 19, 1994)
was an American quantum chemist and biochemist, widely regarded as the premier chemist of the twentieth century. Pauling was a pioneer in the application of quantum mechanics to chemistry, and in 1954 was awarded the Nobel Prize in chemistry for his work describing the nature of chemical bonds. He also made important contributions to crystal and protein structure determination, and was one of the founders of molecular biology. Pauling received the Nobel Peace Prize in 1962 for his campaign against above-ground nuclear testing, becoming only one of four people in history to individually receive two Nobel Prizes. Later in life, he became an advocate for regular consumption of massive doses of Vitamin C. Pauling coined the term "orthomolecular" to refer to the practice of varying the concentration of substances normally present in the body to prevent and treat disease, and promote health.
Pauling was first introduced to the concept of high-dose vitamin C by biochemist Irwin Stone in 1966 and began taking several grams every day to prevent colds. Excited by the results, he researched the clinical literature and published "Vitamin C and the Common Cold" in 1970. He began a long clinical collaboration with the British cancer surgeon, Ewan Cameron, MD [5] in 1971 on the use of intravenous and oral vitamin C as cancer therapy for terminal patients. Cameron and Pauling wrote many technical papers and a popular book, "Cancer and Vitamin C", that discussed their observations. He later collaborated with the Canadian physician, Abram Hoffer, MD, PhD,[6] on a micronutrient regimen, including high-dose vitamin C, as adjunctive cancer therapy.
The selective toxicity of vitamin C for cancer cells has been demonstrated repeatedly in cell culture studies. The Proceedings of the National Academy of Sciences [7] recently published a paper demonstrating vitamin C killing cancer cells. As of 2005, some physicians have called for a more careful reassessment of vitamin C, especially intravenous vitamin C, in cancer treatment.
With two colleagues, Pauling founded the Institute of Orthomolecular Medicine in Menlo Park, California, in 1973, which was soon renamed the Linus Pauling Institute of Science and Medicine. Pauling directed research on vitamin C, but also continued his theoretical work in chemistry and physics until his death in 1994. In his last years, he became especially interested in the possible role of vitamin C in preventing atherosclerosis and published three case reports on the use of lysine and vitamin C to relieve angina pectoris. In 1996, the Linus Pauling Institute moved from Palo Alto, California, to Corvallis, Oregon, to become part of Oregon State University, where it continues to conduct research on micronutrients, phytochemicals (chemicals from plants), and other constituents of the diet in preventing and treating disease.
The name originates from the Greek chole- (bile) and stereos (solid), as researchers first identified cholesterol (C27H45OH) in solid form in gallstones
Common Hazel is cultivated for its nuts. The name hazelnut applies to the nuts of any of the species of the genus Corylus. This hazelnut or cob nut, the kernel of the seed, is edible and used raw or roasted, or ground into a paste. The cob is round, compared with the longer filbert nut.
Pauling was first introduced to the concept of high-dose vitamin C by biochemist Irwin Stone in 1966 and began taking several grams every day to prevent colds. Excited by the results, he researched the clinical literature and published "Vitamin C and the Common Cold" in 1970. He began a long clinical collaboration with the British cancer surgeon, Ewan Cameron, MD [5] in 1971 on the use of intravenous and oral vitamin C as cancer therapy for terminal patients. Cameron and Pauling wrote many technical papers and a popular book, "Cancer and Vitamin C", that discussed their observations. He later collaborated with the Canadian physician, Abram Hoffer, MD, PhD,[6] on a micronutrient regimen, including high-dose vitamin C, as adjunctive cancer therapy.
The selective toxicity of vitamin C for cancer cells has been demonstrated repeatedly in cell culture studies. The Proceedings of the National Academy of Sciences [7] recently published a paper demonstrating vitamin C killing cancer cells. As of 2005, some physicians have called for a more careful reassessment of vitamin C, especially intravenous vitamin C, in cancer treatment.
With two colleagues, Pauling founded the Institute of Orthomolecular Medicine in Menlo Park, California, in 1973, which was soon renamed the Linus Pauling Institute of Science and Medicine. Pauling directed research on vitamin C, but also continued his theoretical work in chemistry and physics until his death in 1994. In his last years, he became especially interested in the possible role of vitamin C in preventing atherosclerosis and published three case reports on the use of lysine and vitamin C to relieve angina pectoris. In 1996, the Linus Pauling Institute moved from Palo Alto, California, to Corvallis, Oregon, to become part of Oregon State University, where it continues to conduct research on micronutrients, phytochemicals (chemicals from plants), and other constituents of the diet in preventing and treating disease.
The name originates from the Greek chole- (bile) and stereos (solid), as researchers first identified cholesterol (C27H45OH) in solid form in gallstones
Common Hazel is cultivated for its nuts. The name hazelnut applies to the nuts of any of the species of the genus Corylus. This hazelnut or cob nut, the kernel of the seed, is edible and used raw or roasted, or ground into a paste. The cob is round, compared with the longer filbert nut.
No comments:
Post a Comment